Connect with us

Uncategorized

Trial for vaccine targeting three different infections

Published

on


A vaccine trial is underway to combat a triple threat of infections with just one single jab.

The University of the Sunshine Coast has started clinical trials of a new Moderna vaccine which works as a triple-barrel shot to target COVID-19, RSV and influenza.

"If you could go to the doctor and get one vaccine that essentially covers you for influenza, COVID-19 and RSV – that would be helpful," Dr Nischal Sahai said.

READ MORE: Sun Cable enters administration, billionaire investor 'fully backs' solar company

"The aim is to see whether a combination vaccine will be as tolerable as giving all three vaccines separately."

The vaccine poses a major shake-up to Australia's annual vaccine rollout to help ease the burden on an overloaded system.

"One visit, one vaccination and possibly a booster compared to three visits and boosters," participant Carolyn Rose said.

"I think that will take a big load off our current health system."

READ MORE: Gladys Berejiklian ICAC report delayed

University of Sunshine Coast trial of vaccine for COVID-19, flu and RSV.

It can take several years to collate enough data before the vaccine can be rolled out safely but researchers are now looking to expand their pool of participants and are calling for more volunteers. 

"We are looking for people who are generally in good health between 50 and 75 – they can be male or female," senior clinical trial coordinator Joan Stark said.

The process includes seven clinic visits and eight phone calls over a period of up to 13 months with all participants compensated.



Source link